ToolsThe story, in brief
AlphaGenome: AI for better understanding the genome
DeepMind just open-sourced a DNA sequence model. Here's why biotech founders should care.
The KeyNews take
Why it matters
DeepMind's AlphaGenome represents a significant capability drop in AI-driven genomic analysis, making regulatory variant prediction accessible via API. This shifts competitive advantage in biotech from proprietary models to those who can best integrate and deploy this foundation model.
The key facts
6 to knowAlphaGenome: unifying DNA sequence model from DeepMind
Advances regulatory variant-effect prediction capability
Available via API for developer/researcher access
Published June 25, 2025
Focuses on genome function interpretation
Foundation model approach (not a traditional software product, but model-as-a-service delivery)
Go to the source
Google DeepMind Blogdeepmind.google
Publisher excerpt: Introducing a new, unifying DNA sequence model that advances regulatory variant-effect prediction and promises to shed new light on genome function — now available via API.